IvyRock Asset Management (HK)’s Legend Biotech LEGN Stock Holding History

IvyRock Asset Management (HK)’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.1M	Sell	801,000 -3,000	-0.4%	-$80.9K	13.08%	3
2026 Q1	$14.5M	Hold	804,000	–	–	8.17%	2
2025 Q4	$17.5M	Sell	804,000 -52,900	-6%	-$1.52M	9.22%	2
2025 Q3	$27.9M	Sell	856,900 -13,000	-1%	-$480K	12.01%	2
2025 Q2	$30.9M	Buy	869,900 +25,900	+3%	+$839K	14.25%	3
2025 Q1	$28.6M	Buy	844,000 +576,900	+216%	+$20.7M	13.46%	3
2024 Q4	$8.69M	Buy	267,100 +260,300	+3,828%	+$10.8M	3.84%	7
2024 Q3	$331K	Buy	+6,800	New	+$362K	0.15%	13

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

IvyRock Asset Management (HK)'s LEGN Position: Q2 2026 in Review

IvyRock Asset Management (HK) reduced its Legend Biotech (LEGN) stake by 0.37% in Q2 2026, selling an estimated $80.9K and leaving 801,000 shares worth $23.1M. The position accounts for 13.08% of the portfolio, ranked #3.

IvyRock Asset Management (HK) first reported a position in LEGN in Q3 2024 and has held it in 8 quarters since. The position peaked at $30.9M in Q2 2025. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

IvyRock Asset Management (HK) held 801,000 shares of Legend Biotech worth $23.1M as of Q2 2026.
IvyRock Asset Management (HK) sold 3,000 Legend Biotech shares in Q2 2026, an estimated $80.9K.
Legend Biotech made up 13.08% of IvyRock Asset Management (HK)'s portfolio in Q2 2026, its #3 holding.
IvyRock Asset Management (HK) first reported a position in Legend Biotech in Q3 2024 and has held it in 8 quarters since.
IvyRock Asset Management (HK)'s Legend Biotech position peaked at $30.9M in Q2 2025.
218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on IvyRock Asset Management (HK)'s 13F filing for Q2 2026, filed 4 Aug 2026.